Myles E. Gombert

1.6k total citations
39 papers, 1.3k citations indexed

About

Myles E. Gombert is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Myles E. Gombert has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Pharmacology and 13 papers in Infectious Diseases. Recurrent topics in Myles E. Gombert's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (10 papers) and Actinomycetales infections and treatment (9 papers). Myles E. Gombert is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (10 papers) and Actinomycetales infections and treatment (9 papers). Myles E. Gombert collaborates with scholars based in United States, France and Germany. Myles E. Gombert's co-authors include T M Aulicino, Michael L. Corrado, L duBouchet, Sheldon H. Landesman, Charles E. Cherubin, Adele Josephson, Lynne V. Karanfil, Marcelino F. Sierra, Robert W. Snyder and Eric D. Donnenfeld and has published in prestigious journals such as JAMA, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Myles E. Gombert

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Myles E. Gombert United States 23 617 309 300 277 244 39 1.3k
Michael A. Saubolle United States 23 1.2k 2.0× 952 3.1× 568 1.9× 60 0.2× 559 2.3× 50 2.1k
J Wüst Switzerland 21 459 0.7× 480 1.6× 111 0.4× 94 0.3× 41 0.2× 75 1.4k
Mercedes Marín Spain 24 958 1.6× 718 2.3× 353 1.2× 41 0.1× 299 1.2× 66 1.8k
H A Gallis United States 16 666 1.1× 500 1.6× 133 0.4× 56 0.2× 115 0.5× 22 1.0k
M. A. Meseguer Spain 14 291 0.5× 166 0.5× 89 0.3× 35 0.1× 86 0.4× 29 727
Yoram Keness Israel 15 370 0.6× 159 0.5× 63 0.2× 53 0.2× 106 0.4× 33 751
R J van Ketel Netherlands 17 474 0.8× 278 0.9× 47 0.2× 98 0.4× 85 0.3× 25 1.2k
Anthony Allworth Australia 21 739 1.2× 610 2.0× 59 0.2× 56 0.2× 86 0.4× 34 1.6k
E.J. Kwak United States 31 1.9k 3.1× 1.3k 4.2× 221 0.7× 372 1.3× 253 1.0× 61 2.9k
Edward J. Young United States 29 979 1.6× 471 1.5× 33 0.1× 82 0.3× 768 3.1× 79 2.3k

Countries citing papers authored by Myles E. Gombert

Since Specialization
Citations

This map shows the geographic impact of Myles E. Gombert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myles E. Gombert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myles E. Gombert more than expected).

Fields of papers citing papers by Myles E. Gombert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myles E. Gombert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myles E. Gombert. The network helps show where Myles E. Gombert may publish in the future.

Co-authorship network of co-authors of Myles E. Gombert

This figure shows the co-authorship network connecting the top 25 collaborators of Myles E. Gombert. A scholar is included among the top collaborators of Myles E. Gombert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myles E. Gombert. Myles E. Gombert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drusano, George L., Sandra L. Preston, M. Van Guilder, et al.. (2000). A Population Pharmacokinetic Analysis of the Penetration of the Prostate by Levofloxacin. Antimicrobial Agents and Chemotherapy. 44(8). 2046–2051. 78 indexed citations
2.
Sandin, Ramón L., et al.. (1998). DisseminatedNocardia BrasiliensisInfection in an Immunocompromised Patient. Cancer Control. 5(1). 64–67. 2 indexed citations
3.
Donnenfeld, Eric D., Amilia Schrier, Henry D. Perry, et al.. (1994). Penetration of Topically Applied Ciprofloxacin, Norfloxacin, and Ofloxacin into the Aqueous Humor. Ophthalmology. 101(5). 902–905. 86 indexed citations
4.
Josephson, Adele, Lynne V. Karanfil, & Myles E. Gombert. (1990). Strategies for the Management of Varicella-Susceptible Healthcare Workers After a Known Exposure. Infection Control and Hospital Epidemiology. 11(6). 309–313. 17 indexed citations
5.
Josephson, Adele, Lynne V. Karanfil, & Myles E. Gombert. (1990). Strategies for the Management of Varicella-Susceptible Healthcare Workers After a Known Exposure. Infection Control and Hospital Epidemiology. 11(6). 309–313. 11 indexed citations
6.
Gombert, Myles E., L duBouchet, T M Aulicino, & Leonard Berkowitz. (1989). Antimicrobial synergism in the therapy of experimental cerebral nocardiosis. Journal of Antimicrobial Chemotherapy. 24(1). 39–43. 22 indexed citations
7.
Gombert, Myles E., L duBouchet, T M Aulicino, Leonard Berkowitz, & Richard J. Macchia. (1989). Brief report: Intravenous ciprofloxacin versus cefotaxime prophylaxis during transurethral surgery. The American Journal of Medicine. 87(5). S250–S251. 12 indexed citations
8.
Gombert, Myles E., et al.. (1988). Airborne Transmission of Nosocomial Varicella from Localized Zoster. The Journal of Infectious Diseases. 158(1). 238–241. 83 indexed citations
9.
Gombert, Myles E.. (1987). A Comparative Trial of Clotrimazole Troches and Oral Nystatin Suspension in Recipients of Renal Transplants. JAMA. 258(18). 2553–2553. 14 indexed citations
10.
Gombert, Myles E. & T M Aulicino. (1986). Amikacin synergism with β-lactam antibiotics against selected nosocomial pathogens. Journal of Antimicrobial Chemotherapy. 17(3). 323–326. 4 indexed citations
11.
Goldstein, Ellie J. C., et al.. (1986). Susceptibility of Eikenella corrodens to newer and older quinolones. Antimicrobial Agents and Chemotherapy. 30(1). 172–173. 22 indexed citations
12.
Gombert, Myles E., et al.. (1986). Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline. Antimicrobial Agents and Chemotherapy. 30(2). 270–273. 61 indexed citations
13.
Goldstein, Ellie J. C., Myles E. Gombert, Marcelino F. Sierra, & Khalid M.H. Butt. (1985). Cefoperazone Therapy of Complicated Urinary Tract Infections: Pharmacokinetics in Renal Transplant Recipients. Chemotherapy. 31(1). 6–12. 3 indexed citations
14.
Josephson, Adele, et al.. (1985). The Relationship Between Intravenous Fluid Contamination and the Frequency of Tubing Replacement. Infection Control. 6(9). 367–370. 70 indexed citations
15.
Gombert, Myles E. & T M Aulicino. (1984). Susceptibility of multiply antibiotic-resistant pneumococci to the new quinoline antibiotics, nalidixic acid, coumermycin, and novobiocin. Antimicrobial Agents and Chemotherapy. 26(6). 933–934. 25 indexed citations
16.
Gombert, Myles E., et al.. (1984). Cefmenoxime therapy of serious bacterial infections. Antimicrobial Agents and Chemotherapy. 25(4). 510–512. 5 indexed citations
17.
Gombert, Myles E., et al.. (1983). Treatment of chromomycosis with ketoconazole and 5-fluorocytosine. Journal of the American Academy of Dermatology. 8(2). 236–238. 27 indexed citations
18.
Gombert, Myles E., Ellie J. C. Goldstein, Jorge L. Benach, et al.. (1982). Human babesiosis. Clinical and therapeutic considerations.. PubMed. 248(22). 3005–7. 33 indexed citations
19.
Gombert, Myles E., et al.. (1982). Erysipelothrix rhusiopathiae Endocarditis. Southern Medical Journal. 75(7). 892–892. 6 indexed citations
20.
Landesman, Sheldon H., et al.. (1980). Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. The American Journal of Medicine. 69(1). 92–98. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Saubolle Breakdown of academic impact, for papers by J Wüst Breakdown of academic impact, for papers by Mercedes Marín Breakdown of academic impact, for papers by H A Gallis Breakdown of academic impact, for papers by M. A. Meseguer Breakdown of academic impact, for papers by Yoram Keness Breakdown of academic impact, for papers by R J van Ketel Breakdown of academic impact, for papers by Anthony Allworth Breakdown of academic impact, for papers by E.J. Kwak Breakdown of academic impact, for papers by Edward J. Young
Rankless by CCL
2026